Pluchea dioscoridis extract: A novel therapeutic approach for polycystic ovary syndrome targeting ovarian morphology, dopamine pathways, and neurobehavior in relation to its phytocomponents
PLOS One · 26.06.2025 · 20 (6) · e0325439
DOI: 10.1371/journal.pone.0325439 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 26.06.2025. Verfasst von Rasha Atta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Physiology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Plant Extracts, Ovary, Dopamine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Polycystic ovarian syndrome (PCOS) is a prevalent endocrine condition associated with hormonal and metabolic abnormalities, as well as behavioral modifications.
Aim
This research assesses the impact of the chemically profiled Pluchea dioscoridis ethanolic extract and metformin in a letrozole-induced polycystic ovary syndrome rat model.
Methods
Thirty female Sprague Dawley rats were allocated into five groups: Control, P. dioscoridis (100 mg/kg), PCOS (letrozole, 1 mg/kg), PCOS + Metformin (300 mg/kg), and PCOS + P. dioscoridis (100 mg/kg), letrazole was given for 8 weeks followed by metformin or P. dioscoridis for 21 days. Behavioral assessments, hormone analyses, and dopamine quantifications in the brain were performed. Ovarian histology and immunohistochemical analysis were conducted.
Results
Letrozole-induced PCOS resulted in heightened depression- and anxiety-like behaviors, along with significant hormonal imbalances compared to the control group (P < 0.05%). Both P. dioscoridis and metformin therapies significantly ameliorated these changes, with P. dioscoridis demonstrating better efficacy. P. dioscoridis medication regulated luteinizing hormone (LH), follicle-stimulating hormone (FSH), testosterone, and estrogen levels, concurrently enhancing cerebral dopamine levels. Histological analysis revealed less cystic follicles and a reinstated normal ovarian architecture in rats treated with P. dioscoridis compared to PCOS group (P < 0.05%). Several flavonoids, nitrogenous compounds and hydroxy cinnamic acid esters were detected in P. dioscoridis samples for the first time utilizing UPLC-ESI-MS analysis.
Conclusion
The P. dioscoridis ethanolic extract exhibited potential medicinal properties that are equivalent to or surpass those of metformin for treating behavioral, hormonal, and ovarian structural abnormalities produced by PCOS. It significantly improved dopamine levels, hormonal balance, and ovarian histology, rendering it a suitable alternative or complementary treatment for PCOS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Physiology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
- Center of Excellence in Molecular and Cellular Medicine (CEMCM), Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
- Department of Histology and Cell Biology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
- Department of Biochemistry and Molecular Biology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
- Department for Life Quality Studies, Rimini Campus, University of Bologna, Rimini, Italy.
- Department of Natural Compounds Chemistry, National Research Centre, Giza, Egypt.
ORCID-Profile: Rasha Atta, Abdelsamed I Elshamy, Mohamed A Zayed, Shimaa Mohammad Yousof
Zitieren
APA
Atta, R., Gouda, S. G., Mohamed, M. H., Afifi, S. M., Nassar, M. I., Farag, M. A., Elshamy, A. I., Zayed, M. A., Alqurashi, T., & Yousof, S. M. (2025). Pluchea dioscoridis extract: A novel therapeutic approach for polycystic ovary syndrome targeting ovarian morphology, dopamine pathways, and neurobehavior in relation to its phytocomponents. PLOS One, 20(6), e0325439. https://doi.org/10.1371/journal.pone.0325439
Vancouver
Atta R, Gouda SG, Mohamed MH, Afifi SM, Nassar MI, Farag MA, et al. Pluchea dioscoridis extract: A novel therapeutic approach for polycystic ovary syndrome targeting ovarian morphology, dopamine pathways, and neurobehavior in relation to its phytocomponents. PLOS One. 2025;20(6):e0325439. doi:10.1371/journal.pone.0325439
BibTeX
@article{Atta2025,
author = {Atta, Rasha and Gouda, Sahar Galal and Mohamed, Marwa Hussein and Afifi, Sherif M and Nassar, Mahmoud I and Farag, Mohamed A and Elshamy, Abdelsamed I and Zayed, Mohamed A and Alqurashi, Thamer and Yousof, Shimaa Mohammad},
title = {Pluchea dioscoridis extract: A novel therapeutic approach for polycystic ovary syndrome targeting ovarian morphology, dopamine pathways, and neurobehavior in relation to its phytocomponents},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {6},
pages = {e0325439},
doi = {10.1371/journal.pone.0325439}
}
EUVIMED